BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 15783062)

  • 21. Target selection and pharma industry productivity: what can we learn from technology S-curve theory?
    Brown D
    Curr Opin Drug Discov Devel; 2006 Jul; 9(4):414-8. PubMed ID: 16889225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New technologies: only a snapshot, but look how far we have come!
    Gavins FN
    Curr Opin Pharmacol; 2012 Oct; 12(5):567-8. PubMed ID: 22944252
    [No Abstract]   [Full Text] [Related]  

  • 23. The impact of systems approaches on biological problems in drug discovery.
    Hood L; Perlmutter RM
    Nat Biotechnol; 2004 Oct; 22(10):1215-7. PubMed ID: 15470453
    [No Abstract]   [Full Text] [Related]  

  • 24. In biomarkers we trust?
    Baker M
    Nat Biotechnol; 2005 Mar; 23(3):297-304. PubMed ID: 15765081
    [No Abstract]   [Full Text] [Related]  

  • 25. Drug development and obstetrics: where are we right now?
    Thornton JG
    J Matern Fetal Neonatal Med; 2009; 22 Suppl 2():46-9. PubMed ID: 19951083
    [No Abstract]   [Full Text] [Related]  

  • 26. Aligning pharmaceutical innovation with medical need.
    Nathan C
    Nat Med; 2007 Mar; 13(3):304-8. PubMed ID: 17342145
    [No Abstract]   [Full Text] [Related]  

  • 27. Growing pains in AIDS drug development.
    Herrera S
    Nat Biotechnol; 2004 Oct; 22(10):1194. PubMed ID: 15470440
    [No Abstract]   [Full Text] [Related]  

  • 28. The pharmaceutical sciences in 2020: report of a conference organized by the board of pharmaceutical sciences of the International Pharmaceutical Federation (FIP).
    Shah VP; Besancon LJ; Stolk P; Tucker G; Crommelin DJ
    Pharm Res; 2010 Mar; 27(3):396-9. PubMed ID: 20107875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PDA Points To Consider: Technical Product Lifecycle Management: Communication and Knowledge Exchange between Marketing Authorization Holders and Health Authorities.
    ; Ramnarine E; Busse U; Colao M; Edwards J; Jornitz M; Munk M; Seymour M; Simianu M; Skeens L; Vinther A
    PDA J Pharm Sci Technol; 2017; 71(2):163-169. PubMed ID: 28089963
    [No Abstract]   [Full Text] [Related]  

  • 30. European Lead Factory hits its stride.
    Kingwell K
    Nat Rev Drug Discov; 2016 Apr; 15(4):221-2. PubMed ID: 27032822
    [No Abstract]   [Full Text] [Related]  

  • 31. Challenges faced by the pharmaceutical industry: training graduates for employment in pharmaceutical R&D.
    Mooney KG
    Eur J Pharm Sci; 2001 Feb; 12(4):353-9. PubMed ID: 11231101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inflammation Research Association: 12th international conference.
    Chantry D; Burgess LE
    Expert Opin Emerg Drugs; 2005 Feb; 10(1):219-24. PubMed ID: 15757413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fundamental problems lie ahead in the drug discovery and commercialization process: restructuring of the pharmaceutical industry and an improved partnership with academia are required.
    Brewer GJ
    J Investig Med; 2006 Sep; 54(6):291-302. PubMed ID: 17191351
    [No Abstract]   [Full Text] [Related]  

  • 34. Controversies in breast cancer 2009.
    Miller WR
    Breast Cancer Res; 2009; 11 Suppl 3(Suppl 3):S1. PubMed ID: 20030860
    [No Abstract]   [Full Text] [Related]  

  • 35. Are the economics of pharmaceutical research and development changing?: productivity, patents and political pressures.
    Grabowski H
    Pharmacoeconomics; 2004; 22(2 Suppl 2):15-24. PubMed ID: 15660474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intellectual property protection: strategies for antibody inventions.
    Storz U
    MAbs; 2011; 3(3):310-7. PubMed ID: 21494091
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The large scale restructuring of pharmaceutical company research function. Preface.
    Lawton G; Witty DR
    Prog Med Chem; 2012; 51():v-vi. PubMed ID: 22520474
    [No Abstract]   [Full Text] [Related]  

  • 38. Theme issue "Solid state and solid dosage forms".
    Kleinebudde P
    Eur J Pharm Biopharm; 2009 Jan; 71(1):1. PubMed ID: 18817869
    [No Abstract]   [Full Text] [Related]  

  • 39. Control systems engineering in continuous pharmaceutical manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
    Myerson AS; Krumme M; Nasr M; Thomas H; Braatz RD
    J Pharm Sci; 2015 Mar; 104(3):832-9. PubMed ID: 25546650
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In the pursuit of industrial proteomics.
    Mitchell P
    Nat Biotechnol; 2003 Mar; 21(3):233-7. PubMed ID: 12610565
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.